Context Capital Management, LLC has filed its 13F form on August 06, 2025 for Q2 2025 where it was disclosed a total value porftolio of $64,000 distributed in 251 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Denali Cap Acquisition Corp Wt with a value of $24K, Climate Rock with a value of $13K, Aimfinity Investment Corp. I with a value of $8K, Ftac Emerald Acquisition Corp. with a value of $8K, and Celularity Inc Wt Exp 05/24/20 with a value of $7K.
Examining the 13F form we can see an decrease of $130K in the current position value, from $194K to 64K .
Below you can find more details about Context Capital Management, LLC portfolio as well as his latest detailed transactions.
Financial Services: $44,000
ETFs: $13,000
Healthcare: $7,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
Fifth Era Acquisition Corp I
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 15.45%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 82.35%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 11.83%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 47.41%
Inflection Pt Acquisition CO
-
$0
0.0% of portfolio
-
Q2 2025
New
Inflection Pt Acquisition CO
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 57.76%
-
$0
0.0% of portfolio
-
Q2 2024
New
Hewlett Packard Enterprise C
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 25.0%
Hennessy Cap Invt Corp Vii
-
$0
0.0% of portfolio
-
Q1 2025
New
Hennessy Cap Invt Corp Vii
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 46.67%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 57.22%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 81.73%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 82.43%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 98.03%
-
$0
0.0% of portfolio
-
Q2 2025
Added 21.71%
-
$0
0.0% of portfolio
-
Q2 2025
Added 34.48%
-
$0
0.0% of portfolio
-
Q2 2025
Added 11.08%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.33%
Drugs Made In Amer Acqutn CO
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2022
New
Digital Asset Acquisition CO
-
$0
0.0% of portfolio
-
Q2 2025
New
Digital Asset Acquisition CO
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.98%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.97%
-
$0
0.0% of portfolio
-
Q1 2025
New
Crane Hbr Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2025
New
Crane Hbr Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 67.48%
Esperion Therapeutics Inc Ne
-
$0
0.0% of portfolio
-
Q1 2025
New
Eqv Ventures Acquisition Cor
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 8.51%
Eqv Ventures Acquisition Cor
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 61.13%
-
$0
0.0% of portfolio
-
Q2 2025
Added 8.09%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 15.08%
-
$0
0.0% of portfolio
-
Q2 2025
Added 52.79%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 53.33%
Embrace Change Acquisitn Cor
-
$0
0.0% of portfolio
-
Q3 2024
New
Embrace Change Acquisitn Cor
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
New
Ecd Automotive Design Inc
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q3 2024
New